David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Department of Chemical Engineering, Center for Bioengineering, University of California, Santa Barbara, CA 93106, USA.
Adv Drug Deliv Rev. 2017 Jan 1;108:51-67. doi: 10.1016/j.addr.2016.01.007. Epub 2016 Jan 20.
Modification of nano/micro-particle physical parameters (e.g. size, shape, surface charge) has proven to be an effective method to enhance their delivery abilities. Recently, advances in particle synthesis have facilitated investigations into the role that particle elasticity plays in modulating drug delivery processes. This review will highlight: (i) methods to tune particle elasticity, (ii) the role particle elasticity plays in cellular internalization, (iii) the role of particle elasticity in modulating circulation times, (iv) the effect of particle elasticity on altering biodistribution and tissue targeting, and (v) the application of computational methods to explain the differences in cellular internalization of particles of different elasticities. Overall, literature reports suggest a complex relationship between particle elasticity and drug delivery processes. Despite this complex relationship, it is clear from numerous in vitro and in vivo studies that particle elasticity is an important parameter that can be leveraged to improve blood circulation, tissue targeting, and specific interactions with cells.
改性纳米/微米颗粒的物理参数(例如大小、形状、表面电荷)已被证明是增强其传递能力的有效方法。最近,颗粒合成技术的进步促进了对颗粒弹性在调节药物传递过程中作用的研究。本文将重点介绍:(i)调节颗粒弹性的方法,(ii)颗粒弹性在细胞内化中的作用,(iii)颗粒弹性在调节循环时间中的作用,(iv)颗粒弹性对改变生物分布和组织靶向的影响,以及(v)计算方法在解释不同弹性颗粒的细胞内化差异中的应用。总体而言,文献报道表明颗粒弹性与药物传递过程之间存在复杂的关系。尽管存在这种复杂的关系,但许多体外和体内研究清楚地表明,颗粒弹性是一个重要的参数,可以利用它来改善血液循环、组织靶向和与细胞的特异性相互作用。
Adv Drug Deliv Rev. 2016-1-20
J Mater Chem B. 2020-3-25
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016
Yao Xue Xue Bao. 2016-2
Pharmaceutics. 2025-6-9
Proc Natl Acad Sci U S A. 2025-4-22
Research (Wash D C). 2025-2-28
Mater Today Bio. 2025-1-29